A Fe-incorporated bioreactor platform exhibiting antimalarial activity and enhanced response to artemisinin.

Antimicrob Agents Chemother · 2026 · PMC13041302 · PMID 41718485

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The 15,089.8 μg/mL treatment group showed highly significant differences compared to controls.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.